TB-500 corresponds to the active N-terminal region of Thymosin Beta-4, a 43-residue protein that is the dominant actin-binding species in most mammalian cell types. The shortened fragment retains the actin-binding motif while being far simpler to synthesise and handle.
It appears frequently in actin polymerisation assays, cell migration and scratch-closure models, angiogenesis preparations, and cardiac remodelling research where cytoskeletal dynamics are the variable of interest.
Supplied as a sealed vial for laboratory use. This material is offered strictly for in vitro research and is not for human or veterinary consumption, diagnostic, or therapeutic use.
Reviews
There are no reviews yet.